The Roche group stepped up its diagnostic activities in 2020 as the coronavirus pandemic created demand for new tests to track the virus and measure a person’s vaccine-induced immune response. Sales of diagnostics were CHF 13.8 billion in 2020 for a rise of 6%. By contrast, pharmaceutical sales fell by 8% to CHF 44.5 billion.
